These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37126863)

  • 1. Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.
    Koning E; Brietzke E
    Trends Psychiatry Psychother; 2024; 46():e20220597. PubMed ID: 37126863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.
    Downey AE; Boyd M; Chaphekar AV; Woolley J; Raymond-Flesch M
    Int J Eat Disord; 2023 Nov; 56(11):2142-2148. PubMed ID: 37551650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.
    Otterman LS
    J Bioeth Inq; 2023 Mar; 20(1):31-39. PubMed ID: 36534233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelics and Psychedelic-Assisted Psychotherapy.
    Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
    Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of psilocybin and MDMA in the treatment of mental illness.
    Gill H; Gill B; Chen-Li D; El-Halabi S; Rodrigues NB; Cha DS; Lipsitz O; Lee Y; Rosenblat JD; Majeed A; Mansur RB; Nasri F; Ho R; McIntyre RS
    Expert Rev Neurother; 2020 Dec; 20(12):1263-1273. PubMed ID: 32954860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the numbers: reimagining healing with psychedelics for eating disorders.
    Lafrance A; Spriggs MJ; Gukasyan N; Peck SK
    J Eat Disord; 2024 Sep; 12(1):148. PubMed ID: 39350242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychedelic-Assisted Therapy for People with Eating Disorders.
    Gukasyan N; Schreyer CC; Griffiths RR; Guarda AS
    Curr Psychiatry Rep; 2022 Dec; 24(12):767-775. PubMed ID: 36374357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
    Pearson C; Siegel J; Gold JA
    J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.
    Foldi CJ; Liknaitzky P; Williams M; Oldfield BJ
    Front Neurosci; 2020; 14():43. PubMed ID: 32116500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective.
    De La Haye W; Walcott G; Eaton J; Beckford J; Greene J
    Front Psychiatry; 2023; 14():1136990. PubMed ID: 37457761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.
    Foldi CJ; Liknaitzky P; Williams M; Oldfield BJ
    Focus (Am Psychiatr Publ); 2024 Jul; 22(3):373-380. PubMed ID: 38988467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psilocybin for Trauma-Related Disorders.
    Khan AJ; Bradley E; O'Donovan A; Woolley J
    Curr Top Behav Neurosci; 2022; 56():319-332. PubMed ID: 35711024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.
    Ledwos N; Rosenblat JD; Blumberger DM; Castle DJ; McIntyre RS; Mulsant BH; Husain MI
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):581-588. PubMed ID: 36193898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psilocybin occasioned mystical-type experiences.
    James E; Robertshaw TL; Hoskins M; Sessa B
    Hum Psychopharmacol; 2020 Sep; 35(5):e2742. PubMed ID: 32573835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review.
    Cuerva K; Spirou D; Cuerva A; Delaquis C; Raman J
    Eur Eat Disord Rev; 2024 Sep; 32(5):980-1001. PubMed ID: 38783636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.
    Greenway KT; Garel N; Jerome L; Feduccia AA
    Expert Rev Clin Pharmacol; 2020 Jun; 13(6):655-670. PubMed ID: 32478631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychedelic drugs for psychiatric disorders.
    da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
    J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal Behavior in Psychedelic Research.
    Odland AU; Kristensen JL; Andreasen JT
    Pharmacol Rev; 2022 Oct; 74(4):1176-1205. PubMed ID: 36180111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compassionate use of psychedelics.
    Greif A; Šurkala M
    Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.